Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MEG.0000000000000676PMID 27271159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of C‐reactive protein levels in patients with cirrhosis

  2015cited by this paper
• The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.

  2015cited by this paper
• New prognostic markers in liver cirrhosis.

  2015cited by this paper
• Cytokine production in patients with cirrhosis and TLR4 polymorphisms.

  2014cited by this paper
• Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.

  2014cited by this paper
• Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

  2013cited by this paper
• Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

  2013cited by this paper
• Uncovering the molecular events associated with increased intestinal permeability in liver cirrhosis: the pivotal role of enterocyte tight junctions and future perspectives.

  2013cited by this paper
• C-reactive protein predicts short-term mortality in patients with cirrhosis.

  2012cited by this paper
• Evidence of neutrophil functional defect despite inflammation in stable cirrhosis.

  2011cited by this paper
• Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.

  2011cited by this paper
• Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage

  2011cited by this paper
• Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

  2010cited by this paper
• Nucleotide‐binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis

  2010cited by this paper
• Infection and inflammation in liver failure: two sides of the same coin.

  2009cited by this paper
• Proinflammatory cytokines in CRP baseline regulation.

  2009cited by this paper
• Influence of pretransplantation bacterial and fungal culture positivity on outcome after living donor liver transplantation.

  2009cited by this paper
• The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.

  2009cited by this paper
• Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis?

  2007cited by this paper
• Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

  2007cited by this paper
• Inflammatory markers in patients with severe burn injury: what is the best indicator of sepsis?

  2007cited by this paper
• Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

  2005cited by this paper
• Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

  2005cited by this paper
• Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.

  2005cited by this paper
• Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis.

  2005cited by this paper
• Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

  2004cited by this paper
• Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation

  2004cited by this paper
• Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction

  2004cited by this paper
• C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study.

  2003cited by this paper
• C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.

  2002cited by this paper
• Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis

  2001cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

  1998cited by this paper
• Guidelines for the Use of Innovative Therapies in Sepsis

  1993cited by this paper
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

  1992cited by this paper

• Interaction of inflammation and portal hypertension in cirrhosis progression

  2025cites this paper
• A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Identifying necrotizing soft tissue infection using infectious fluid analysis and clinical parameters based on machine learning algorithms

  2024cites this paper
• Predictor of gram-negative bacteremia in cirrhotic patients with skin and soft-tissue infections

  2023cites this paper
• Surgical site infections are independently associated with the development of postoperative acute-on-chronic liver failure in liver cirrhosis

  2023cites this paper
• Factors predicting mortality in patients with alcoholic liver cirrhosis visiting the emergency department

  2023cites this paper
• Predictive Value of Red Blood Cell Distribution Width, Platelet Count to Lymphocyte Count Ratio, and Neutrophil Count to Lymphocyte Count Ratio Values for the Detection of Postoperative Infection in Patients Undergoing Liver Transplantation.

  2023cites this paper
• Serum 25‐hydroxyvitamin D and C‐reactive protein and plasma von Willebrand concentrations in 23 dogs with chronic hepatopathies

  2022cites this paper
• Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis

  2022cites this paper
• Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation.

  2021cites this paper
• The Addition of C-Reactive Protein and von Willebrand Factor to MELD-Na Improves Prediction of Waitlist Mortality

  2021cites this paper
• High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study.

  2021cites this paper
• Translocation of gut microbiota in liver cirrhosis: mechanisms, clinical significance, and markers

  2021cites this paper
• Higher liver stiffness in patients with chronic congestive heart failure: data from NHANES with liver ultrasound transient elastography.

  2021cites this paper
• The Addition of C‐Reactive Protein and von Willebrand Factor to Model for End‐Stage Liver Disease‐Sodium Improves Prediction of Waitlist Mortality

  2021cites this paper
• University of Groningen A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms

  2020cites this paper
• Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis

  2020cites this paper
• A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study †

  2020cites this paper
• The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis

  2020cites this paper
• БАКТЕРИАЛЬНАЯ ТРАНСЛОКАЦИЯ В ПАТОГЕНЕЗЕ ОСЛОЖНЕНИЙ ЦИРРОЗА ПЕЧЕНИ

  2020cites this paper
• TRANSLOCATION OF INTESTINAL MICROFLORA IN CIRRHOSIS

  2020cites this paper
• Prise en charge et surveillance de la cirrhose

  2020cites this paper
• Copeptin – a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease

  2019cites this paper
• Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?

  2019cites this paper
• von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis

  2019cites this paper
• Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study

  2019cites this paper
• Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial

  2019cites this paper
• Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications

  2018cites this paper
• Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

  2018cites this paper
• Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.

  2018cites this paper
• The Diagnostic and Prognostic Values of C-Reactive Protein and Procalcitonin during Bacterial Infections in Decompensated Cirrhosis

  2018cites this paper
• Human beta‐defensin‐1 is a highly predictive marker of mortality in patients with acute‐on‐chronic liver failure

  2018cites this paper
• Accuracy of calprotectin using the Quantum Blue Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis

  2018cites this paper
• Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

  2017cites this paper
• Are we still searching for the fifth element of MELD?

  2017cites this paper
• Preliver transplant red cell distribution width predicts postliver transplant mortality

  2017cites this paper
• Reply to: "Are we still searching for the fifth element of MELD?"

  2017cites this paper
• Bacterial translocation markers in liver cirrhosis

  2017cites this paper
• Title: Pre-Liver Transplant Red Cell Distribution Width Predicts Post-Liver Transplant Mortality Running Head: Pre-LT RDW Predicts Post-LT Mortality

  2017cites this paper
• Increased Level of Interleukin 6 Associates With Increased 90‐Day and 1‐Year Mortality in Patients With End‐Stage Liver Disease

  2017cites this paper
• Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis

  2016cites this paper
• New prognostic markers in liver cirrhosis.

  2015cites this paper